GlassScriptPhysician profile
John Thomas Daniels
NPI 1235105420
$9,417.37
in general payments reported to CMS, 2019-2025
39 companies · $2,808 in 2025
The $2,808 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.58 · 2020: $303 · 2021: $989 · 2022: $1,876 · 2023: $1,418 · 2024: $1,939 · 2025: $2,808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,137 · Education: $28.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,136.78 |
| Education | $28.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,657.87 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,524.52 | 2020-2025 | Trelegy Ellipta, Nucala |
| Regeneron Healthcare Solutions, INC. | $845.39 | 2021-2025 | Dupixent |
| Grifols USA, LLC | $530.70 | 2020-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $502.24 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $473.72 | 2021-2025 | Glassia |
| Insmed, INC. | $473.09 | 2021-2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $463.59 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System, Hillrom - Life 2000 Ventilation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $449.37 | 2019-2025 | Ofev, Jascayd |
| Mylan Specialty L.P. | $395.62 | 2019-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $343.38 | 2022-2025 | Opsumit, Opsynvi |
| Amgen INC. | $274.48 | 2024-2025 | Tezspire, Tavneos |
| Axsome Therapeutics, INC. | $268.55 | 2023-2025 | Sunosi |
| Jazz Pharmaceuticals INC. | $209.97 | 2022 | |
| Harmony Biosciences LLC | $160.26 | 2022-2025 | Wakix |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.